Predicting pathology on small bowel capsule endoscopy: a good FIT

Abstract

Background and study aims Small bowel capsule endoscopy [SBCE) has an established role in investigating suspected small bowel bleeding [SSBB). Identification of a biomarker to predict pathology would maximize utility of this valuable diagnostic modality. This study aimed to investigate if fecal immunochemical test [FIT) could predict likelihood of small bowel pathology on SBCE.

Patients and methods Patients referred for SBCE to investigate anaemia or suspected small bowel bleeding were prospectively recruited. All patients had negative upper and lower endoscopy prior to referral. A FIT ≥ 45 ug Hb/g was considered positive. SBCE was positive if a potential source of SSBB was identified. The primary endpoint was correlation between FIT and positive SBCE. Secondary endpoints were correlation between anemia and SBCE and a combination of anemia plus FIT and SBCE.

Results Fifty-one patients were included in the final study cohort. 29.4 % had a positive FIT, 33.3 % were anemic, and 25.5 % patients had significant SBCE findings. There was a statistically significant association between positive FIT and pathology on SBCE (OR 12, 95 % CI [2.8 – 51.9), P = 0.001). Sensitivity and specificity of positive FIT in predicting SBCE findings were 69 % and 84 %, respectively. A normal Hb had an NPV of 83 % (OR 0.30, P = 0.09). Combining Hb and FIT was statistically significant in predicting pathology on SBCE (OR 9.14, 67 % PPV, 82 % NPV, P = 0.025).

Conclusion FIT ≥ 45 ug Hb/g is a useful tool in predicting small bowel pathology on SBCE. Use of this biomarker alone, or in combination with serum haemoglobin, has value as a screening tool and may help to better triage patients referred for SBCE.

• References

• 1 Gerson LB, Fidler JL, Cave DR. et al. ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding. Am J Gastroenterol 2015; 110: 1265-1287 ; quiz 1288
• 2 Szold A, Katz LB, Lewis BS. Surgical approach to occult gastrointestinal bleeding. Am J Surg 1992; 163: 90-93
• 3 Tee H-P, Kaffes AJ. Non-small-bowel lesions encountered during double-balloon enteroscopy performed for obscure gastrointestinal bleeding. World J Gastroenterol 2010; 16: 1885-1889
• 4 Pennazio M, Arrigoni A, Risio M. et al. Clinical evaluation of push-type enteroscopy. Endoscopy 1995; 27: 164-170
• 5 de Leusse A, Vahedi K, Edery J. et al. Capsule endoscopy or push enteroscopy for first-line exploration of obscure gastrointestinal bleeding?. Gastroenterology 2007; 132: 855-862
• 6 Teshima CW, Kuipers EJ, van Zanten SV. et al. Double balloon enteroscopy and capsule endoscopy for obscure gastrointestinal bleeding: an updated meta-analysis. J Gastroenterol Hepatol 2011; 26: 796-801
• 7 Harbord M, Annese V, Vavricka SR. et al. ThefFirst European evidence-based consensus on extra-intestinal manifetations in inflammatory bowel disease. J Crohns Colitis 2016; 10: 239-254
• 8 Pennazio M, Santucci R, Rondonotti E. et al. Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: report of 100 consecutive cases. Gastroenterology 2004; 126: 643-653
• 9 Singh A, Marshall C, Chaudhuri B. et al. Timing of video capsule endoscopy relative to overt obscure GI bleeding: implications from a retrospective study. Gastrointest Endosc 2013; 77: 761-766
• 10 Katsinelos P, Chatzimavroudis G, Terzoudis S. et al. Diagnostic yield and clinical impact of capsule endoscopy in obscure gastrointestinal bleeding during routine clinical practice: a single-center experience. Med Princ Pract Int J Kuwait Univ Health Sci Cent 2011; 20: 60-65
• 11 Navarro M, Nicolas A, Ferrandez A. et al. Colorectal cancer population screening programs worldwide in 2016: An update. World J Gastroenterol 2017; 23: 3632-3642
• 12 Lin JS, Piper MA, Perdue LA. et al. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2016; 315: 2576-2594
• 13 Park JJ, Cheon JH. §#/ITL#§ Small bowel evaluation in asymptomatic fecal immunochemical test-positive patients with a negative colonoscopy: is it necessary?. Dig Dis Sci 2011; 56: 2773-2775
• 14 Pennazio M, Spada C, Eliakim R. et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2015; 47: 352-386
• 15 Yung DE, Vijayan S, Avni T. et al. Fecal occult blood testing for the prediction of small-bowel pathology detected by capsule endoscopy: a systematic review and meta-analysis. Ann Gastroenterol Q Publ Hell Soc Gastroenterol 2017; 30: 186-191
• 16 Ransohoff DF, Sox HC. Clinical practice guidelines for colorectal cancer screening: new recommendations and new challenges. JAMA 2016; 315: 2529-2531
• 17 Mowat C, Digby J, Strachan JA. et al. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms. Gut 2016; 65: 1463-1469
• 18 Guidelines for Quality Assurance in Colorectal Screening. Second Edition (Internet). National Screening Service , Available from: https://www.bowelscreen.ie/_fileupload/Documents/BS%20-%20Guidelines%20for%20Quality%20Assurance%20in%20Colorectal%20Screening%20-%202nd%20EDITION%20(web).pdf
• 19 Gibson DJ, Nolan B, Rea J. et al. A prospective study of faecal immunochemical testing following polypectomy in a colorectal cancer screening population. Frontline Gastroenterol 2018; 9: 295-299
• 20 Palimaka S, Blackhouse G, Goeree R. Capsule endoscopy in the assessment of obscure gastrointestinal bleeding: an economic analysis. Ont Health Technol Assess Ser 2015; 15: 1-32
• 21 Meulen MP van der, Kapidzic A, Leerdam ME van. et al. Do men and women need to be screened differently with fecal immunochemical testing? a cost-effectiveness analysis. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 2017; 26: 1328-1336
• 22 Shiotani A, Tarumi K, Honda K. et al. Application of fecal hemoglobin-haptoglobin complex testing for small bowel lesions. Scand J Gastroenterol 2014; 49: 539-544